Press "Enter" to skip to content

The Finance Herald

Purple Biotech Is Building Next-Generation Cancer Immunotherapy in a Space Where Deals Are Measured in Billions (NASDAQ: PPBT)

Purple Biotech’s CAPTN-3 platform uses conditionally activated tri-specific antibody technology, part of a broader class of multispecific antibodies that has commanded $700 million+ upfront payments and multi-billion-dollar transactions across the…

Navigating the Inevitable: Embracing Change in an Era of Decline

Growing numbers of individuals are recognizing that current global challenges—spanning economic, political, and social spheres—have reached unprecedented severity within their lifetimes. Many are seeking guidance to understand where these trends…